Search results for "Organo"

showing 10 items of 1460 documents

Preparation and characterization of bio-organoclays using nonionic surfactant

2015

The present study was aimed at the preparation and characterization of tailor made hybrid materials, whose peculiar hosting capability could be exploited in biotechnological applications. With this purpose, the modification of K10 montmorillonite by intercalation of Tween 20 surfactant, was accomplished. The influence of two internal parameters, namely pH and surfactant/clay ratio, on the surfactant uptake ability by clay was investigated. The adsorption mechanism was elucidated on the basis of complementary kinetic and equilibrium studies and, then, corroborated by the useful information provided by the FT-IR, TGA and XRD characterization. The gathered results allow to draw the conclusion …

Adsorption kineticGeneral Chemical EngineeringIntercalation (chemistry)Drug delivery systemTween 20Dual mode model02 engineering and technology010402 general chemistrycomplex mixtures01 natural scienceschemistry.chemical_compoundAdsorptionPulmonary surfactantOrganic chemistryNonionic surfactantChemical Engineering (all)MontmorilloniteOrgano-clayIsothermHydrophobic drugChemistry (all)Surfaces and InterfacesGeneral Chemistry021001 nanoscience & nanotechnology0104 chemical sciencesCharacterization (materials science)MontmorillonitechemistryChemical engineering0210 nano-technologyHybrid materialSurfaces and Interface
researchProduct

A new principle to normalize plasma concentrations allowing single-sample clearance determinations in both children and adults.

1992

A sufficiently accurate quantification of renal function requiring only one plasma sample without an additional gamma-camera study has, until now, only been possible in adults. A new principle will be presented here allowing the universal application of known algorithms, regardless of the clearance substance used, by normalizing the plasma concentrations with respect to the individual body dimensions of the patients - for infants as well as for adults. In this respect, algorithms are developed for clearance determinations using technetium-99m mercaptoacetyltriglycine (99mTc-MAG3), which are based on steady-state studies as the reference. They allow the calculation of quantitative clearance …

AdultAdolescentRenal functionSingle sampleKidneylaw.inventionRenal CirculationTechnetium Tc 99m MertiatidelawBlood plasmaMedicineHumansRadiology Nuclear Medicine and imagingChildRadionuclide ImagingGamma camerabusiness.industryInfant NewbornInfantGeneral MedicineOrganotechnetium CompoundsStandard errorChild PreschoolPlasma concentrationbusinessNuclear medicineQuantitative analysis (chemistry)OligopeptidesAlgorithmsBlood samplingEuropean journal of nuclear medicine
researchProduct

Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocard…

2007

N-terminal pro-b-type natriuretic peptide (NT pro-BNP) is a neurohormone synthesized predominantly in ventricular myocardium. In patients with symptoms of heart failure, elevation in NT pro-BNP accurately identifies ventricular dysfunction. However, NT pro-BNP levels are not specific for ventricular dysfunction in patients who do not have overt symptoms of heart failure, suggesting that other cardiac processes such as myocardial ischemia may also cause elevation in NT pro-BNP. The study was aimed to determine whether NT pro-BNP elevations are associated with myocardial ischemia.One hundred and thirty patients (104 males, 26 females, mean age 61+12 years), with ST elevation acute myocardial …

AdultAged 80 and overMaleTomography Emission-Computed Single-PhotonMyocardial InfarctionMyocardial IschemiaOrganotechnetium CompoundsMiddle AgedSensitivity and SpecificityPeptide FragmentsElectrocardiographyLogistic ModelsOrganophosphorus CompoundsROC CurvePredictive Value of TestsNatriuretic Peptide BrainExercise TestOdds RatioHumansFemaleRadiopharmaceuticalsBiomarkersAgedEchocardiography StressRetrospective Studies
researchProduct

Determination of 21 perfluoroalkyl substances and organophosphorus compounds in breast milk by liquid chromatography coupled to orbitrap high-resolut…

2018

Abstract The human exposure to perfluoroalkyl (PFASs) and organophosphorus (OPs) compounds is a cause of concern and its determination in biological matrices, including human milk, is an emergent approach for evaluate their exposure. A comprehensive strategy for the quantitative determination of 21 PFASs and OPs compounds in breast milk was developed. The proposed method includes an extraction and clean-up procedure based on the QuEChERs methodology followed by an ultra-high performance liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) determination. The full-scan mass data were acquired with a resolution of 50000 FWHM and a mass accuracy better than 5 ppm. Met…

AdultAnalyteResolution (mass spectrometry)Food Contamination02 engineering and technologyBreast milkQuechersMass spectrometryOrbitrap01 natural sciencesBiochemistryMass SpectrometryAnalytical Chemistrylaw.inventionOrganophosphorus CompoundslawPlasticizersEnvironmental ChemistryHumansSpectroscopyFlame RetardantsDetection limitFluorocarbonsChromatographyMilk HumanChemistry010401 analytical chemistryRepeatability021001 nanoscience & nanotechnology0104 chemical sciencesSpainFemale0210 nano-technologyChromatography LiquidAnalytica chimica acta
researchProduct

A phase IIA study of the topoisomerase I inhibitor, exatecan mesylate (DX-8951f), administered at two different dose schedules in patients with plati…

2004

OBJECTIVES: There is an urgent need for new agents with activity in platinum- and taxane-resistant epithelial ovarian cancer. Exatecan mesylate is a novel topoisomerase I inhibitor with potent activity against ovarian cancer in vitro. A multicentre phase IIA study was conducted in patients with platinum- and taxane-resistant epithelial ovarian cancer. PATIENTS AND METHODS: Fifty-seven patients with bidimensionally measurable ovarian cancer, previously exposed to platinum and taxanes, whose disease had relapsed within 6 months of platinum-containing chemotherapy were randomised to one of two intravenous schedules of exatecan mesylate; 0.3 mg/m(2) daily for 5 days every 3 weeks (Arm A) or 2.1…

AdultBridged-Ring Compoundsmedicine.medical_specialtyOrganoplatinum Compoundsmedicine.medical_treatmentPharmacologyNeutropeniaGastroenterologyDrug Administration Schedulechemistry.chemical_compoundRefractoryInternal medicineAntineoplastic Combined Chemotherapy ProtocolsMedicineHumansExatecanEnzyme InhibitorsAgedOvarian NeoplasmsChemotherapyTaxanebusiness.industryObstetrics and GynecologyExatecan mesylateMiddle Agedmedicine.diseaseAntineoplastic Agents PhytogenicDrug Resistance MultipleRegimenOncologychemistryDrug Resistance NeoplasmCamptothecinFemaleTaxoidsTopoisomerase I InhibitorsbusinessOvarian cancer
researchProduct

RCBF-quantification with 99mTc-HMPAO-SPECT: theory and first results.

1989

The activity concentrations of 99mTc-HMPAO in brain after intravenous injection were evaluated in 25 patients using SPECT. With additional first pass studies of heart and brain with the short lived isotope 195mAu, the cardiac output and the mean cerebral transit times of the patients were measured a short time before the HMPAO injection. The time dependence of 99mTc-HMPAO activity in the brain was registered during the first 5 min after injection over both hemispheres. Using a simplified three compartment model it was possible to calculate the mean retention fraction of HMPAO in brain from the time activity curves. It could be shown that the regional cerebral blood flow in ml/min per 100 g …

AdultCardiac outputCorrelation coefficientAdolescentHemodynamicsGrey matterTechnetium Tc 99m ExametazimeOximesmedicineOrganometallic CompoundsHumansRadiology Nuclear Medicine and imagingChild99mtc hmpao spectAgedmedicine.diagnostic_testbusiness.industryBrainTechnetiumGeneral MedicineMiddle Agedmedicine.anatomical_structureCerebral blood flowPositron emission tomographyCerebrovascular CirculationbusinessNuclear medicineTechnetium-99mTomography Emission-ComputedEuropean journal of nuclear medicine
researchProduct

Development of a novel methodology for determination of dialkyl phosphates in human urine using liquid chromatography-tandem mass spectrometry

2019

Abstract In this study a fast and sensitive method was developed for the quantitative determination of six dialkyl phosphates (DAPs) in human urine using liquid chromatography-tandem mass spectrometry (LC-MS/MS). The proposed methodology was based on liquid-liquid extraction (LLE) with diethyl ether and ethyl acetate using MgSO4 and NaCl, followed by liquid chromatography and mass spectrometry detection in the selected reaction mode (SRM) with negative electrospray ionization (ESI-). Detection settings were optimized by design of experiments (DoE). Dibutyl phosphate (DBP) was used as internal standard. Several criteria established in the SANTE/11813/2017 guidance document for pesticide resi…

AdultElectrospray ionizationClinical BiochemistryEthyl acetateMass spectrometry030226 pharmacology & pharmacy01 natural sciencesBiochemistryPhosphatesAnalytical ChemistryYoung Adult03 medical and health scienceschemistry.chemical_compoundOrganophosphorus Compounds0302 clinical medicineLimit of DetectionTandem Mass SpectrometryLiquid–liquid extractionLiquid chromatography–mass spectrometryHumansLactationChromatography High Pressure LiquidDetection limitChromatography010401 analytical chemistryExtraction (chemistry)Pesticide ResiduesReproducibility of ResultsCell BiologyGeneral Medicine0104 chemical scienceschemistryLinear ModelsFemaleDiethyl etherJournal of Chromatography B
researchProduct

Concentrations and determinants of organochlorine levels among pregnant women in Eastern Spain

2010

Persistent organic pollutants (POPs) comprise a large variety of toxic substances with ample distribution. While exposure to these toxins occurs mainly through diet, maternal POP levels may be influenced by certain sociodemographic, environmental, or lifestyle factors. This is important given that these substances may have adverse effects on fetal development. The aim of this study is to examine the sociodemographic, environmental, lifestyle, and dietary determinants of the levels of hexachlorobenzene (HCB), b-hexachlorocyclohexane (b-HCH), 1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane (4,4′-DDT), 1,1-dichloro-2,2-bis(4-chlorophenyl)ethylene (4,4′-DDE), and polychlorinated biphenyls (PCB co…

AdultEnvironmental EngineeringDichlorodiphenyl DichloroethyleneDDTchemistry.chemical_compoundPregnancyEnvironmental healthmedicineHexachlorobenzeneHydrocarbons ChlorinatedEnvironmental ChemistryHumansWaste Management and DisposalPersistent organic pollutantPregnancyPCBOrganochlorine compoundCohortfood and beveragesHexachlorobenzenemedicine.diseasePollutionDietchemistryMaternal ExposureSpainEnvironmental chemistryCohortPopulation studyEnvironmental PollutantsFemaleBreast feedingBody mass indexHexachlorocyclohexaneCohort study
researchProduct

Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for Breast MR ima…

2011

To intraindividually compare 0.1 mmol/kg doses of gadobenate dimeglumine and gadopentetate dimeglumine for contrast material-enhanced breast magnetic resonance (MR) imaging by using a prospective, multicenter double-blind, randomized protocol.Institutional review board approval and patient informed consent were obtained. One hundred sixty-two women (mean age, 52.8 years ± 12.3 [standard deviation]) enrolled at 17 sites in Europe and China between July 2007 and May 2009 underwent at least one breast MR imaging examination at 1.5 T by using three-dimensional spoiled gradient-echo sequences. Of these, 151 women received both contrast agents in randomized order in otherwise identical examinatio…

AdultGadolinium DTPAChinaContrast MediaBreast NeoplasmsSensitivity and Specificitylaw.inventionDouble blindbreast neoplasm contrast media MRIBreast cancerMegluminebreast neoplasmRandomized controlled trialDouble-Blind MethodlawPredictive Value of TestsImage Interpretation Computer-AssistedmedicineOrganometallic CompoundsHumansRadiology Nuclear Medicine and imagingProspective StudiesProspective cohort studyGADOBENATE DIMEGLUMINEAgedAged 80 and overChi-Square DistributionCross-Over Studiesbusiness.industryMiddle Agedmedicine.diseaseMr imagingCrossover studyMagnetic Resonance ImagingEuropeFemaleBreast diseaseNuclear medicinebusinessMRIRadiology
researchProduct

Focal nodular hyperplasia: a weight-based, intraindividual comparison of gadobenate dimeglumine and gadoxetate disodium-enhanced MRI

2019

PURPOSE: We aimed to qualitatively and quantitatively compare the enhancement pattern of focal nodular hyperplasia after gadobenate dimeglumine and gadoxetate disodium injection in the same patient. METHODS: 1.5 T magnetic resonance imaging (MRI) examinations of 16 patients with 21 focal nodular hyperplasias studied after the injection of both contrast media were evaluated. Both MRI studies were performed in all patients. A qualitative analysis was performed evaluating each lesion in all phases. For quantitative analysis we calculated signal intensity ratio, lesion-to-liver contrast ratio and liver parenchyma signal intensity gain on hepatobiliary phase. Statistical analysis was performed w…

AdultGadolinium DTPAMaleContrast MediaLiver MRI neoplasm030218 nuclear medicine & medical imagingGadoxetate DisodiumLesion03 medical and health sciences0302 clinical medicineMcNemar's testMegluminemedicineOrganometallic CompoundsHumansRadiology Nuclear Medicine and imagingIntraindividual comparisonAbdominal ImagingGADOBENATE DIMEGLUMINERetrospective Studiesmedicine.diagnostic_testbusiness.industryLiver NeoplasmsFocal nodular hyperplasiaMagnetic resonance imagingMiddle Agedmedicine.diseaseImage EnhancementMagnetic Resonance ImagingLiverEvaluation Studies as TopicFocal Nodular HyperplasiaFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessNuclear medicineSettore MED/36 - Diagnostica Per Immagini E RadioterapiaWeight based dosing
researchProduct